CVS Group plc Block Listing Application (5744Y)
May 05 2023 - 3:53AM
UK Regulatory
TIDMCVSG
RNS Number : 5744Y
CVS Group plc
05 May 2023
5 May 2023
CVS Group plc
("CVS" or the "Company")
Block Listing Application
CVS, one of the UK's leading providers of integrated veterinary
services, announces that an application has been made to the
Financial Conduct Authority and the London Stock Exchange for the
admission of 120,000 of its ordinary shares of 0.2p each in the
Company ("Ordinary Shares") to trading on AIM.
The Ordinary Shares will be reserved under a block listing and
will be issued in connection with the grant, vesting and/or
exercise of awards under the terms of the Company's Long Term
Incentive Plans ("LTIP"). It is expected that the majority of the
shares reserved under the block listing will satisfy the exercise
of options in connection with the next LTIP vesting on 2 October
2023.
When issued, the Ordinary Shares under the block listing will
rank pari passu with the Company's existing issued Ordinary Shares.
It is anticipated that the block-listed shares will be admitted on
11 May 2023.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Jenny Farrer, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418
8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Letaba Rimell +44 (0)7789 151 644
About CVS Group plc ( www.cvsukltd.co.uk )
CVS Group is an AIM-quoted fully-integrated provider of
veterinary services in the UK, with practices in the Netherlands
and the Republic of Ireland. CVS is focused on providing high
quality clinical services to its customers and their animals, with
outstanding and dedicated clinical teams and support colleagues at
the core of its strategy.
The Group has c.500 veterinary practices across its three
markets, including eight specialist referral hospitals and 37
dedicated out-of-hours sites. Alongside the core Veterinary
Practices division, CVS operates Laboratories (providing diagnostic
services to CVS and third-parties), Crematoria (providing pet
cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business
("Animed Direct").
The Group employs c.8,500 personnel, including c.2,200
veterinary surgeons and c.3,100 nurses.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALSUPUGAAUPWUMA
(END) Dow Jones Newswires
May 05, 2023 03:53 ET (07:53 GMT)
CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Oct 2024 to Oct 2024
CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Oct 2023 to Oct 2024